Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor–Induced Adrenal Insufficiency: A Case Report

Journal of Immunotherapy · Published 2026-06-08 · DOI 10.1097/cji.0000000000000609

Authors (5)

Nila N. Sabetfakhri, Hibba Tul Rehman, Deborah L. Cook, Kaitlyn V. Barrett, Jessica A. Cintolo-Gonzalez

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Sabetfakhri, N., Rehman, H., Cook, D., et al. (2026). Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor–Induced Adrenal Insufficiency: A Case Report. Journal of Immunotherapy. https://doi.org/10.1097/cji.0000000000000609

Related articles